Results 11 to 20 of about 9,289 (213)
Three-Dimensional Transjugular Intrahepatic Portosystemic Shunt Geometry Predicts Shunt Dysfunction. [PDF]
Aliment Pharmacol TherRegarding the role of 3D TIPS geometry in predicting TIPS dysfunction, this study identified a larger distance of the cranial stent end from the inferior vena cava and a larger stent curvature as predictors of dysfunction. Therefore, a less curved, more central TIPS is recommended to reduce the risk of dysfunction ABSTRACT Background Patients with ...
Meyer C +13 more
europepmc +2 more sources
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS
Hepatology, EarlyView., 2022 The river diagram demonstrates that after transjugular intrahepatic portosystemic shunt insertion (TIPS) the majority of patients without ascites and 50% of the patients with ascites detectable at ultrasound, show the best response in the long term follow‐up.
Alexander Queck +14 more
wiley +1 more source
Health disparities in chronic liver disease
Hepatology, EarlyView., 2022 Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian +3 more
wiley +1 more source
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
Hepatology, EarlyView., 2022 Diagram of the activation of the profibrotic and procontractile Janus kinase 2 (JAK2)/Ras homolog family member A/Rho‐kinase pathway and the inhibition of phosphorylated JAK2 by pacritinib to inhibit hepatic stellate cell activity. Abstract Background and Aims Janus kinase 2 (JAK2) signaling is increased in human and experimental liver fibrosis with ...
Sandra Torres +21 more
wiley +1 more source
SAGE Open Medical Case Reports, 2023 Budd-Chiari syndrome is a rare disease characterized by the obstruction of hepatic venous outflow. Stepwise treatment options aimed to relieve obstruction and prevent complications of Budd-Chiari syndrome are medical therapy, interventional ...
Werimo Pascal Kuka +3 more
doaj +1 more source
Transjugular Intrahepatic Portosystemic Shunt [PDF]
Seminars in Interventional Radiology, 2008 Transjugular intrahepatic portosystemic shunt (TIPS) insertion is among the most technically challenging procedures in interventional radiology. It combines many of the skills used in other procedures such as venous access, biopsy, angioplasty, and stent-graft insertion into one IR tour de force.
openaire +3 more sources
CVIR Endovascular, 2023 Background Transmesenteric access for portal vein reconstruction and transjugular intrahepatic portosystemic shunt allows for intervention in patients with unfavorable anatomy and can be performed via multiple methods but may be difficult to obtain in ...
Mari Tanaka, Kei Yamada, Sanjeeva Kalva
doaj +1 more source
Journal of Medical Case Reports, 2011 Introduction Recent data suggest that mucosal abnormalities can occur even in the duodenum, jejunum, and distal ileum of cirrhosis patients. We present a case of portal hypertensive enteropathy in a cirrhosis patient shown by capsule endoscopy and the ...
Carella Alessandra +6 more
doaj +1 more source
Canadian Journal of Gastroenterology, 2010 BACKGROUND: Gastric variceal bleeding (GVB) is a major cause of morbidity and mortality among patients with portal hypertension. Endoscopic band ligation and standard sclerotherapy have been used but have significant limitations.
Jaber Al-Ali +5 more
doaj +1 more source
CVIR Endovascular, 2022 Introduction Direct intrahepatic portosystemic shunt creation is a feasible and safe alternative for transjugular intrahepatic portosystemic shunt creation. It needs equipment like endovascular ultrasound with restricted availability.
Karim Mostafa +5 more
doaj +1 more source